loader

Green Pill_Apr’24

The XVI Volume of The Green Pill explores the emerging fault lines in the ESG landscape, with pro- and anti- ESG pThe XVI Volume of The Green Pill explores the emerging fault lines in the ESG landscape, with pro- and anti- ESG proponents making their voices more shrill. This comes in the backdrop of the investment performance of anti-ESG assets and claims by certain quarters that investors ought to focus on returns, firstly and lastly. The volume explores the paths being taken by gung-ho regulators, contrasting them to various shades of the anti-ESG movement, and calls for effective leadership to avert the crisis.

    Subscribe to content and reports from SBICAPS

    I hereby provide my consent to share my email id with SBICAPS for the purpose of availing the service of subscription to the content and reports from SBICAPS and let them use, share and retain it to provide, analyse, administer, enhance and extend their service.